Empagliflozin and renal sodium handling : an intriguing smart osmotic diuretic
| Errataetall: |
CommentOn: Eur J Heart Fail. 2021 Jan;23(1):68-78. - PMID 33251643 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
European journal of heart failure - 23(2021), 1 vom: 22. Jan., Seite 79-82 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mullens, Wilfried [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9NEZ333N27 |
|---|
| Anmerkungen: |
Date Completed 05.07.2021 Date Revised 05.07.2021 published: Print-Electronic CommentOn: Eur J Heart Fail. 2021 Jan;23(1):68-78. - PMID 33251643 Citation Status MEDLINE |
|---|
| doi: |
10.1002/ejhf.2086 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31936514X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31936514X | ||
| 003 | DE-627 | ||
| 005 | 20231225171307.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ejhf.2086 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1064.xml |
| 035 | |a (DE-627)NLM31936514X | ||
| 035 | |a (NLM)33372343 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mullens, Wilfried |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Empagliflozin and renal sodium handling |b an intriguing smart osmotic diuretic |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.07.2021 | ||
| 500 | |a Date Revised 05.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Eur J Heart Fail. 2021 Jan;23(1):68-78. - PMID 33251643 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Benzhydryl Compounds |2 NLM | |
| 650 | 7 | |a Diuretics, Osmotic |2 NLM | |
| 650 | 7 | |a Glucosides |2 NLM | |
| 650 | 7 | |a Sodium |2 NLM | |
| 650 | 7 | |a 9NEZ333N27 |2 NLM | |
| 650 | 7 | |a empagliflozin |2 NLM | |
| 650 | 7 | |a HDC1R2M35U |2 NLM | |
| 700 | 1 | |a Martens, Pieter |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of heart failure |d 1999 |g 23(2021), 1 vom: 22. Jan., Seite 79-82 |w (DE-627)NLM106698575 |x 1879-0844 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2021 |g number:1 |g day:22 |g month:01 |g pages:79-82 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ejhf.2086 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2021 |e 1 |b 22 |c 01 |h 79-82 | ||